Home > Financial Ratios > GLENMARK PHARMACEUTICALS

GLENMARK PHARMACEUTICALS
Fixed Capital/Sales

    Back to All Ratios
GLENMARK PHARMACEUTICALS is part of below Screeners ↓
Best Quarterly Growth Mid Cap Stocks
Best 1M Momentum Mid Cap Stocks
COMMUNITY POLL
for GLENMARK PHARMACEUTICALS
Please provide your vote to see the results

GLENMARK PHARMACEUTICALS Last 5 Year Fixed Capital/Sales History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
   Fixed Capital/Sales(x) 0.320.350.360.360.34

What is the latest Fixed Capital/Sales ratio of GLENMARK PHARMACEUTICALS ?

The latest Fixed Capital/Sales ratio of GLENMARK PHARMACEUTICALS is 0.32 based on Mar2026 Consolidated results.
Year Fixed Capital/Sales
Mar20260.32
Mar20250.35
Mar20240.36
Mar20230.36
Mar20220.34

How is Fixed Capital/Sales of GLENMARK PHARMACEUTICALS Trending?

Years Fixed Capital/Sales % Change
Mar2026 0.32
-8.57
Mar2025 0.35
-2.78
Mar2024 0.36
0.00
Mar2023 0.36
5.88
Mar2022 0.34 -

Other Financial Ratios of GLENMARK PHARMACEUTICALS


Compare Fixed Capital/Sales ratio of peers of GLENMARK PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GLENMARK PHARMACEUTICALS ₹70,263.6 Cr 4% 11.5% 28.7% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹469,310.0 Cr 2% -1.7% 15.9% Stock Analytics
DIVIS LABORATORIES ₹245,426.0 Cr 6.5% 14.8% 48.4% Stock Analytics
TORRENT PHARMACEUTICALS ₹189,347.0 Cr 1.2% -2.5% 37.2% Stock Analytics
CIPLA ₹114,393.0 Cr -0.3% -3.9% -11.4% Stock Analytics
DR REDDYS LABORATORIES ₹97,240.2 Cr -2.2% 1.5% -8.3% Stock Analytics


GLENMARK PHARMACEUTICALS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
GLENMARK PHARMACEUTICALS

4%

11.5%

28.7%

SENSEX

-0.5%

-1.3%

-5.4%


You may also like the below Video Courses